Work

Supplementary Figure 1 from Efficacy of RG7787, a Next-Generation Mesothelin-Targeted Immunotoxin, against Triple-Negative Breast and Gastric Cancers

Year: 2023
Type: supplementary-materials
Abstract: Supplementary Figure 1. Shows evaluation of MSLN expression in the TCGA breast cancer data set
Language: English
Subfield: Immunology
Open Access status: gold
OpenAlex ID: W4362547743
Cites:
Cited by:
Related to: 10